Franklin Resources’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $83.8M | Sell |
1,027,327
-94,061
| -8% | -$6.79M | 0.02% | 522 |
|
|
2026
Q1 | $76.4M | Sell |
1,121,388
-165,297
| -13% | -$11.7M | 0.02% | 506 |
|
|
2025
Q4 | $97.7M | Buy |
1,286,685
+129,651
| +11% | +$9.42M | 0.02% | 438 |
|
|
2025
Q3 | $71M | Sell |
1,157,034
-117,726
| -9% | -$6.13M | 0.02% | 524 |
|
|
2025
Q2 | $62.3M | Buy |
1,274,760
+1,752
| +0.1% | +$83.2K | 0.02% | 557 |
|
|
2025
Q1 | $64.9M | Sell |
1,273,008
-5,180
| -0.4% | -$258K | 0.02% | 526 |
|
|
2024
Q4 | $57.7M | Sell |
1,278,188
-130,826
| -9% | -$5.6M | 0.02% | 568 |
|
|
2024
Q3 | $55.1M | Sell |
1,409,014
-61,336
| -4% | -$2.05M | 0.02% | 565 |
|
|
2024
Q2 | $45M | Sell |
1,470,350
-11,138
| -0.8% | -$361K | 0.01% | 580 |
|
|
2024
Q1 | $43.1M | Buy |
1,481,488
+55,110
| +4% | +$1.54M | 0.01% | 620 |
|
|
2023
Q4 | $39.3M | Sell |
1,426,378
-630,855
| -31% | -$14.4M | 0.02% | 579 |
|
|
2023
Q3 | $46.1M | Sell |
2,057,233
-1,254,671
| -38% | -$46.7M | 0.02% | 517 |
|
|
2023
Q2 | $135M | Sell |
3,311,904
-133,894
| -4% | -$6.55M | 0.06% | 310 |
|
|
2023
Q1 | $167M | Sell |
3,445,798
-43,889
| -1% | -$2.01M | 0.08% | 271 |
|
|
2022
Q4 | $133M | Sell |
3,489,687
-979,088
| -22% | -$40.7M | 0.07% | 313 |
|
|
2022
Q3 | $224M | Sell |
4,468,775
-443,035
| -9% | -$21.7M | 0.12% | 203 |
|
|
2022
Q2 | $197M | Sell |
4,911,810
-254
| -0% | -$8.91K | 0.1% | 244 |
|
|
2022
Q1 | $183M | Buy |
4,912,064
+30,850
| +0.6% | +$1.19M | 0.07% | 317 |
|
|
2021
Q4 | $194M | Buy |
4,881,214
+68,157
| +1% | +$2.61M | 0.07% | 313 |
|
|
2021
Q3 | $179M | Sell |
4,813,057
-976,937
| -17% | -$40.1M | 0.07% | 323 |
|
|
2021
Q2 | $245M | Buy |
5,789,994
+310,792
| +6% | +$13.3M | 0.09% | 250 |
|
|
2021
Q1 | $259M | Sell |
5,479,202
-96,981
| -2% | -$5.76M | 0.11% | 227 |
|
|
2020
Q4 | $340M | Buy |
5,576,183
+3,933
| +0.1% | +$232K | 0.14% | 183 |
|
|
2020
Q3 | $261M | Buy |
5,572,250
+160,677
| +3% | +$7.91M | 0.13% | 199 |
|
|
2020
Q2 | $257M | Sell |
5,411,573
-109,009
| -2% | -$5.36M | 0.13% | 188 |
|
|
2020
Q1 | $246M | Buy |
5,520,582
+50,274
| +0.9% | +$2.53M | 0.16% | 165 |
|
|
2019
Q4 | $263M | Buy |
5,470,308
+41,659
| +0.8% | +$1.77M | 0.14% | 188 |
|
|
2019
Q3 | $184M | Buy |
5,428,649
+1,240,509
| +30% | +$54M | 0.1% | 245 |
|
|
2019
Q2 | $188M | Buy |
4,188,140
+443,764
| +12% | +$17.5M | 0.1% | 241 |
|
|
2019
Q1 | $141M | Buy |
3,744,376
+530,083
| +16% | +$17.8M | 0.08% | 286 |
|
|
2018
Q4 | $110M | Buy |
3,214,293
+588,659
| +22% | +$21.2M | 0.07% | 307 |
|
|
2018
Q3 | $123M | Buy |
+2,625,634
| New | +$109M | 0.06% | 328 |
|
|
2016
Q4 | – | Sell |
-397,800
| Closed | -$5.57M | – | 1504 |
|
|
2016
Q3 | $5.57M | Hold |
397,800
| – | – | ﹤0.01% | 1084 |
|
|
2016
Q2 | $2.79M | Hold |
397,800
| – | – | ﹤0.01% | 1206 |
|
|
2016
Q1 | $2.56M | Hold |
397,800
| – | – | ﹤0.01% | 1213 |
|
|
2015
Q4 | $12.9M | Hold |
397,800
| – | – | 0.01% | 953 |
|
|
2015
Q3 | $10.6M | Hold |
397,800
| – | – | 0.01% | 1007 |
|
|
2015
Q2 | $19.1M | Hold |
397,800
| – | – | 0.01% | 897 |
|
|
2015
Q1 | $24.2M | Hold |
397,800
| – | – | 0.01% | 843 |
|
|
2014
Q4 | $20.6M | Hold |
397,800
| – | – | 0.01% | 864 |
|
|
2014
Q3 | $17.5M | Hold |
397,800
| – | – | 0.01% | 905 |
|
|
2014
Q2 | $10.4M | Hold |
397,800
| – | – | ﹤0.01% | 1048 |
|
|
2014
Q1 | $10.4M | Buy |
397,800
+19,500
| +5% | +$524K | ﹤0.01% | 1021 |
|
|
2013
Q4 | $6.42M | Hold |
378,300
| – | – | ﹤0.01% | 1091 |
|
|
2013
Q3 | $8.12M | Buy |
+378,300
| New | +$6.57M | ﹤0.01% | 1023 |
|
Other funds holding PTCT
RI
JT
Franklin Resources's PTCT Position: Q2 2026 in Review
Franklin Resources reduced its PTC Therapeutics (PTCT) stake by 8.4% in Q2 2026, selling an estimated $6.79M and leaving 1,027,327 shares worth $83.8M. The position accounts for 0.02% of the portfolio, ranked #522.
Franklin Resources first reported a position in PTCT in Q3 2013 and has held it in 45 quarters since. The position peaked at $340M in Q4 2020. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Franklin Resources held 1,027,327 shares of PTC Therapeutics worth $83.8M as of Q2 2026.
- Franklin Resources sold 94,061 PTC Therapeutics shares in Q2 2026, an estimated $6.79M.
- PTC Therapeutics made up 0.02% of Franklin Resources's portfolio in Q2 2026, its #522 holding.
- Franklin Resources first reported a position in PTC Therapeutics in Q3 2013 and has held it in 45 quarters since.
- Franklin Resources's PTC Therapeutics position peaked at $340M in Q4 2020.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.